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summARy – fallopian tube cancer is least common of all gynecologic tumors, with the mean 
age at onset between 54 and 63 years. This case report presents a 67-year-old female, gravida 1, para 
1, with primary adenocarcinoma of the fallopian tube, detected and diagnosed preoperatively in 
clinical stage iiic. The patient was asymptomatic, with only mild vaginal discharge of amber color 
and normal measured value of CA 125. The diagnosis was based on routine clinical and ultrasound 
examination, followed by surgery, surgical-pathological staging of the disease, and finally paclitaxel 
and platinum based chemotherapy. The patient has been in remission for nine years now.
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Introduction
fallopian tube cancer is least common of all gyne-
cologic tumors, accounting for only 0.1% to 0.4% of 
all gynecologic tumors. The reported incidence ranges 
from 0.29 to 0.36/100 000. The mean age at onset 
is between 54 and 63 years1. The etiology of the fal-
lopian tube cancer is unknown, although infertility, 
hormonal and genetic factors are considered as the 
possible causative factors2. mutations of the bRCA1 
gene were found in 16%-34% of women with primary 
fallopian tube cancer3. The risk is lower in women 
on oral hormonal contraceptives and in pluriparous 
breastfeeding women. nulliparous women have better 
prognosis than pluriparous women, although pluri-
parity is considered as a protective factor2.
Clinical manifestations of the disease are lower 
abdominal pain, amber vaginal discharge (which ap-
pears in 29% of patients) and pelvic masses (adnexal 
tumor occurs in 26% of all cases), i.e. latzko’s triad4,5. 
The level of CA 125 can be elevated in 59%-100% of 
patients, but it is not considered specific for cancer of 
the fallopian tube4. in more than 90% of cases, these 
tumors histologically belong to the group of serous 
adenocarcinoma2.
due to clinical, therapeutic and prognostic simi-
larities with ovarian cancer in staging, a modified 
classification for ovarian cancer is used. staging is 
done according to surgical-pathological classification 
provided by fiGo6. 
fallopian tube cancer spreads mainly transcoelomi-
cally, similar to ovarian cancer, and per continuitatem to 
the adjacent structures, ovaries and uterus4. lymphatic 
metastases are usually found in pelvic and para-aortic 
lymph nodes. The most commonly affected group of 
lymph nodes are those belonging to the inferior mesen-
teric artery7. According to the literature, lymph nodes 
were positive in 36% to 55% of patients that underwent 
lymphadenectomy8. surgical treatment is intended pri-
marily for early stages of fallopian tube cancer5.
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external irradiation, intraperitoneal applications 
of isotopes, vaginal and uterine radioactive implants 
are the possible ways of radiotherapy5. out of the total 
number of patients with fallopian tube cancer, up to 
43% have signs of peritoneal tumor invasion and ap-
proximately 30% have para-aortic lymph nodes posi-
tive for metastasis7. Therefore, as in cases of ovarian 
cancer, the recommended chemotherapy protocols are 
based on platinum and paclitaxel9.
survival rate depends on the stage of the disease, 
tumor maturity (grade), invasion of the muscular layer 
of the tuba, lymphovascular space involvement, and 
presence of inflammatory reactions7. five-year surviv-
al rate for stage i is 95%, stage ii 75%, stage iii 69%, 
and stage iV 45%2. in general, fallopian tube cancer 
has better prognosis than ovarian cancer3.
Case Report
A patient aged 67, gravida 1, para 1, postmeno-
pausal for 15 years, without a history of oral con-
traceptive use or hormone replacement therapy, was 
admitted to the Clinical department of Gynecology 
and obstetrics, osijek university hospital Center. 
on regular gynecologic examination, a small cylin-
drical tumor mass was detected, located in the left 
adnexal area, immobile and tender to deep palpation. 
The patient complained only of ‘yellowish mucous’ 
vaginal discharge. Papanicolaou test was taken, but it 
was negative for malignancies.
ultrasound revealed uterus of normal size and 
endometrium divided with liquid measuring 13 mm 
(mucometra). left ovary was converted to anechogen-
ic cyst measuring 59x65 mm, smooth-walled, without 
papillae or septa, with poorly vascularized capsule, 
and with normal color doppler Resistance index (Ri). 
Above the cystic formation, a solid cylinder shaped 
tumor, 15 cm long and 3 to 5 cm wide, abundantly 
vascularized with pathologic color doppler Ri mea-
suring between 0.34 and 0.39, was detected. CA 125 
level was 31.1 iu /ml.
A decision was made to perform laparotomy in 
order to make complete evaluation. laparotomy re-
vealed normal uterus with left ovary that was turned 
into a cystic mass and left tuba turned into a tumor 
formation consisting mainly of solid material that was 
stretched between the uterus, cavum douglasi, rectum 
and pelvic side wall. tubal ostia were covered with a 
cauliflower-like abdominal tumor (fig. 1). 
since there was no ascites present, peritoneal la-
vage was performed. Cytologic examination revealed 
that there were no malignant cells present. This lim-
ited the operation to hysterectomy with adnexectomy, 
omentectomy, multiple biopsies of the peritoneum, 
pelvic and para-aortic lymph node sampling, with 
necessary adhesiolysis of the tumor and surround-
ing structures. histopathologic examination showed 
a tumor of the fallopian tube measuring 15x10 cm, 
enormously enlarging the tuba that was filled with 
Fig. 1. Primary serous papillary adenocarcinoma of the 
fallopian tube.
Fig. 2. Transition from benign to malignant epithelium of 
the fallopian tube. 
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solid tumor formations composed of clusters of highly 
atypical epithelial cells with low differentiation, poly-
morphism and mitosis (figs. 2 and 3). The tumor, al-
though poorly differentiated, still mimicked the struc-
ture of the fallopian tube. The omentum had normal 
histologic structure without any metastasis present; 
however, tumor tissue was found in two of 19 lymph 
nodes removed from the lymph nodes belonging to 
the area of the common iliac artery. tumor cells were 
also found in the tissue removed from serosa of the 
rectosigmoid colon.
The patient’s postoperative course was unevent-
ful. Adjuvant polychemotherapy based on paclitaxel 
and carboplatin was administered, for the duration of 
six cycles. The patient has been regularly followed up 
for the past nine years at our gynecologic oncology 
department, and has been free from any signs of the 
disease.
Discussion 
This case report presents a patient with gynecolog-
ic tumors, found at the surgical-pathological fiGo 
stage iiic using appropriate diagnostic procedure and 
correct surgical staging. except for the ‘yellowish’ 
vaginal discharge, the patient had no other symptoms 
of the disease, although it was in an advanced stage. 
According to the literature, 20% of patients were as-
ymptomatic, and only 3% were correctly diagnosed 
preoperatively1. The specific amber vaginal discharge, 
which is present in more than 50% of the patients, has 
a predictive value of 11%-60% for abnormal cytologic 
findings8. CA 125 level may be higher in 59%-100% 
of patients, but it is not specific for cancer of the fal-
lopian tube10.
in comparison with similar cases10,11, this patient 
belongs to the group of most common histologic sub-
type (serous adenocarcinoma, 56%) and stage (stage 
iii, 39%). however, according to the literature, the 
median follow up was 39.6 months and overall sur-
vival rate 34%9.
According to ultrasound criteria previously de-
scribed by Kurjak et al.12, the finding of a large highly 
vascularized solid tumor mass, usually within the fal-
lopian tube, especially when associated with patho-
logic values of the color doppler Ri, can with high 
probability lead to the diagnosis of a primary tumor of 
the fallopian tube. in this case, the diagnosis of simple 
ovarian cyst was also helpful. since this was the case 
of advanced cancer, the pathologist had no difficulty 
in making the diagnosis of primary fallopian tube 
cancer.                    
in the initial stages of the disease, the following 
four criteria as modified by sedlis13 in 1978 should be 
met to set the histologic diagnosis of primary fallo-
pian tube cancer: the tumor arises from the endosalp-
ynx; the histologic pattern reproduces the epithelium 
of the tubal mucosa; transition from benign to malig-
nant epithelium; and the ovaries are either normal or 
with a tumor smaller than that of the tube.
tubal carcinoma spreads mainly transcoelomi-
cally, but in this case the spread was per continuitatem 
to the rectosigmoid bowel and pelvic side wall, with 
lymphatic spread to the parailiac lymph nodes, even 
though, according to the literature, most commonly 
affected are lymph nodes around the inferior mesen-
teric artery7. Although there are no strict diagnos-
tic and therapeutic guidelines, fallopian tube cancer 
diagnosis should be based on typical clinical signs, 
transvaginal ultrasound and pulsating color doppler; 
CA 125 and the finding of malignant cells in the am-
ber vaginal discharge can also be useful4,10. in some 
cases, malignant cells can be found in cervical Pap 
smear, as reported in the literature14. Therapy should 
be primarily surgical and it should be based on exact 
surgical-pathological staging, followed by adjuvant 
chemotherapy based on paclitaxel and platinum. in 
advanced stages, an optimal cytoreduction and che-
motherapy are an option15.
Fig. 3. Histopathologic image of the fallopian tube tumor. 
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by following the principles in this case, the patient 
with advanced primary carcinoma of the fallopian 
tube has managed to survive free from recurrences for 
nine years after initial treatment.
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sažetak
PRimARni seRoZni PAPilARni AdenoKARCinom JAJoVodA
Z. Topolovec, M. Mrčela, S. Šijanović, D. Vidosavljević i A. Milostić Srb
Rak jajovoda je najrjeđi među svim ginekološkim tumorima s najvećom incidencijom u dobnoj skupini od 54 do 63 
godine. Rad prikazuje primarni adenokarcinom jajovoda kod 67-godišnje bolesnice, gravida 1, para 1, otkriven i prijeope-
racijski dijagnosticiran u kliničkom stadiju iiic. bolesnica je bila asimptomatska, a jedini simptom je bio blagi vaginalni 
iscjedak jantarne boje, uz uredne izmjerene vrijednosti CA 125. dijagnoza se temeljila na kliničkom pregledu i ultrazvuč-
noj dijagnostici, nakon čega je potvrđena perioperacijski, kroz kirurško-patološko određivanje stupnja proširenosti. nakon 
operacijskog zahvata bolesnica je podvrgnuta kemoterapiji zasnovanoj na paklitakselu i platini. bolesnica se devet godina 
nalazi u remisiji. 
Ključne riječi: Tuba uterina, tumori – dijagnostika; Tuba uterina, tumori – kirurgija; Adenokarcinom, papilarni – dijagno-
stika; Adenokarcinom, papilarni – kirurgija; Prikaz slučaja
